Argonaute protein (Ago) exists in almost all organisms. In eukaryotes, functions as a system for the regulation of gene expression. In prokaryotes, it is a kind of defense against invasive alien genome. Ago system has been engineered to silence genes and genome editing and play an important role in biological studies.
With an increasing number of genomes and proteomes of various microbes become available, computational tools to identify and annotating argonaute protein is needed. We introduce AGONOTES (Argonaute Note). This is a web service designed specifically for identifying and annotating Ago. AGONOTES using BLASTP similarity search algorithm to categorize all proteins are delivered into three groups: argonaute prokaryotic protein (Pago), argonaute eukaryotic proteins (EAGO), and non-argonaute protein (non-Ago).
Argonaute proteins can then be adjusted to match the standard set Ago sequence using the program MUSCLE multiple sequence alignment. All functional domains can be further Ago curated from the alignment and visualized easily through the module Bio :: Graphic in bundles BioPerl. Compared with the existing tools such as CD-Search and the available databases such as UniProt and AGONOTES show much better performance on domain explanation, which is the basis for studying the new Ago. AGONOTES freely accessible in https://i.uestc.edu.cn/agonotes/. AGONOTES is a friendly tool for annotating Ago domain of the proteome, or a series of protein sequences.
Tuning the molecular and electronic properties of Pt (II) complex -organic have profound effects on their application in the fields of technology, medicine and engineering crystals. Here, we present a combination of infrared and Raman spectroscopic investigations on trans-PtCl2 (PEt3) 2 systematically carried out at various temperatures from 300 to 4.2 K in various spectral. Studies suggest orientational change drastically different from the group at around 180 K and 130 K in the group of ligands bound to the central Pt atom. This is accompanied by systematic strengthening of hydrogen bonds C-H ⋯ Cl in the temperature range 180-130 K.
Untransduced T Cells |
|||
| 78170-2 | BPS Bioscience | 5 vials | EUR 3325 |
|
Description: The untransduced T cells are produced by mock lentiviral transduction of human primary CD4+CD8+ T cells. These cells are subjected to comparable manipulations as CAR-T cells: activation, spinoculation (without lentivirus), and expansion. These T cells are meant to be negative controls in experiments using lentivirus-transduced primary CAR-T cells. |
|||
CD4+ T cells, Negatively Selected (Human) |
|||
| 79752 | BPS Bioscience | 10 million cells | EUR 395 |
|
Description: Cryopreserved vial (10 x 10^6 cells) of CD4+ T cells that were negatively selected from freshly isolated primary human peripheral blood mononuclear cells (PBMCs). The PBMCs came from a healthy donor, and were isolated from whole blood or leukapheresis samples using a Ficoll gradient. Magnetic antibodies to monocytes, granulocytes, CD8+ T cells, gamma/delta T cells and other immune subsets present in PBMCs were then used to purify untouched CD4+ T cells via immunomagnetic separation. Before and after CD4+ T cell isolation, the cells were stained to evaluate purity and viability by flow cytometry. Cells were cryopreserved in CryoStor CS10 cryopreservation medium (Stemcell, #07930) at a controlled rate._x000D_Source Normal human PBMC from Leukapheresis Sample |
|||
CD8+ T cells, Negatively Selected (Human) |
|||
| 79753 | BPS Bioscience | 10 million cells | EUR 495 |
|
Description: Cryopreserved vial (10 x 10^6 cells) of CD8+ T cells that were negatively selected from freshly isolated primary human peripheral blood mononuclear cells (PBMCs). The PBMCs came from a healthy donor, and were isolated from whole blood or leukapheresis samples using a Ficoll gradient. Magnetic antibodies to monocytes, granulocytes, CD4+ T cells, gamma/delta T cells and other immune subsets present in PBMCs were then used to purify untouched CD8+ T cells via immunomagnetic separation. Before and after CD8+ T cell isolation, the cells were stained to evaluate purity and viability by flow cytometry. Cells were cryopreserved in CryoStor CS10 cryopreservation medium (Stemcell, #07930) at a controlled rate._x000D_Source Normal human PBMC from Leukapheresis Sample |
|||
Anti-CD19 CAR-T Cells |
|||
| 78171-1 | BPS Bioscience | 1 vial | EUR 1595 |
|
Description: The anti-CD19 CAR-T cells are produced by high-titer lentiviral transduction of human primary CD4+CD8+ T cells using the anti-CD19 CAR Lentivirus (CD19 ScFv-CD8-4-1BB-CD3ζ; SIN Vector, BPS Bioscience, #78601). These ready-to use CAR-T cells express an anti-CD19 CAR consisting the ScFv of CD19 (clone FMC63) linked to a 2nd generation CAR (Chimeric Antigen Receptor) containing CD8 hinge and transmembrane domains, and the 4-1BB and CD3ζ signaling domains. These CAR-T cells have been validated using flow cytometry (to determine the CAR expression) and co-culture cytotoxicity assays. |
|||
Anti-CD19 CAR-T Cells |
|||
| 78171-2 | BPS Bioscience | 5 vials | EUR 4250 |
|
Description: The anti-CD19 CAR-T cells are produced by high-titer lentiviral transduction of human primary CD4+CD8+ T cells using the anti-CD19 CAR Lentivirus (CD19 ScFv-CD8-4-1BB-CD3ζ; SIN Vector). These ready-to use CAR-T cells express an anti-CD19 CAR consisting the ScFv of CD19 (clone FMC63) linked to a 2nd generation CAR (Chimeric Antigen Receptor) containing CD8 hinge and transmembrane domains, and the 4-1BB and CD3ζ signaling domains.These CAR-T cells have been validated using flow cytometry (to determine the CAR expression) and co-culture cytotoxicity assays. |
|||
Anti-BCMA CAR-T Cells |
|||
| 78660-1 | BPS Bioscience | 1 vial | EUR 1595 |
|
Description: The anti-BCMA CAR-T cells are produced by high-titer lentiviral transduction of human primary CD4+CD8+ T cells using the anti-BCMA CAR Lentivirus (BPS Bioscience #78655). These ready-to-use CAR-T cells express an anti-BCMA CAR consisting of the ScFv of BCMA (clone C11D5.3) linked to a 2nd generation CAR (Chimeric Antigen Receptor) containing CD8 hinge and transmembrane domains, and the 4-1BB and CD3ζ signaling domains (Figure 1). These CAR-T cells have been validated using flow cytometry (to determine the CAR expression) and co-culture cytotoxicity assays. |
|||
Anti-BCMA CAR-T Cells |
|||
| 78660-2 | BPS Bioscience | 5 vials | EUR 4250 |
|
Description: The anti-BCMA CAR-T cells are produced by high-titer lentiviral transduction of human primary CD4+CD8+ T cells using the anti-BCMA CAR Lentivirus (BPS Bioscience #78655). These ready-to-use CAR-T cells express an anti-BCMA CAR consisting of the ScFv of BCMA (clone C11D5.3) linked to a 2nd generation CAR (Chimeric Antigen Receptor) containing CD8 hinge and transmembrane domains, and the 4-1BB and CD3ζ signaling domains (Figure 1). These CAR-T cells have been validated using flow cytometry (to determine the CAR expression) and co-culture cytotoxicity assays. |
|||
anti-CD4 T helper cells |
|||
| 502-A-01mg | Virogen | 0,1 mg | EUR 321 |
|
Description: anti-CD4 T helper cells |
|||
anti-CD4 T helper cells |
|||
| 502-A-1000ug | Virogen | 1000 ug | EUR 1539 |
|
Description: anti-CD4 T helper cells |
|||
anti-CD8 T cytotoxic/supressor cells |
|||
| 505-A-01mg | Virogen | 0,1 mg | EUR 321 |
|
Description: anti-CD8 T cytotoxic/supressor cells |
|||
anti-CD8 T cytotoxic/supressor cells |
|||
| 505-A-1000ug | Virogen | 1000 ug | EUR 1539 |
|
Description: anti-CD8 T cytotoxic/supressor cells |
|||
Human Normal Peripheral Blood CD4+/CD25+ Regulatory T Cells (T reg), Fresh |
|||
| PBCD4-25-F2M | 101Bio | - | Ask for price |
Human Normal Peripheral Blood CD4+/CD25+ Regulatory T Cells (T reg), Cryopreserved |
|||
| PBCD4-25-C2M | 101Bio | - | Ask for price |
CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody |
|||
| BNC432884-100 | Biotium | 100uL | EUR 279.6 |
|
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), CF543 conjugate, Concentration: 0.1mg/mL |
|||
CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody |
|||
| BNC432884-500 | Biotium | 500uL | EUR 654 |
|
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), CF543 conjugate, Concentration: 0.1mg/mL |
|||
CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody |
|||
| BNC052884-100 | Biotium | 100uL | EUR 279.6 |
|
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), CF405M conjugate, Concentration: 0.1mg/mL |
|||
CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody |
|||
| BNC052884-500 | Biotium | 500uL | EUR 654 |
|
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), CF405M conjugate, Concentration: 0.1mg/mL |
|||
CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody |
|||
| BNC402884-100 | Biotium | 100uL | EUR 279.6 |
|
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), CF640R conjugate, Concentration: 0.1mg/mL |
|||
CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody |
|||
| BNC402884-500 | Biotium | 500uL | EUR 654 |
|
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), CF640R conjugate, Concentration: 0.1mg/mL |
|||
CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody |
|||
| BNC472884-100 | Biotium | 100uL | EUR 279.6 |
|
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), CF647 conjugate, Concentration: 0.1mg/mL |
|||
CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody |
|||
| BNC472884-500 | Biotium | 500uL | EUR 654 |
|
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), CF647 conjugate, Concentration: 0.1mg/mL |
|||
CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody |
|||
| BNC802884-100 | Biotium | 100uL | EUR 279.6 |
|
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), CF680 conjugate, Concentration: 0.1mg/mL |
|||
CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody |
|||
| BNC802884-500 | Biotium | 500uL | EUR 654 |
|
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), CF680 conjugate, Concentration: 0.1mg/mL |
|||
CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody |
|||
| BNC612884-100 | Biotium | 100uL | EUR 279.6 |
|
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), CF660R conjugate, Concentration: 0.1mg/mL |
|||
CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody |
|||
| BNC612884-500 | Biotium | 500uL | EUR 654 |
|
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), CF660R conjugate, Concentration: 0.1mg/mL |
|||
CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody |
|||
| BNC552884-100 | Biotium | 100uL | EUR 279.6 |
|
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), CF555 conjugate, Concentration: 0.1mg/mL |
|||
CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody |
|||
| BNC552884-500 | Biotium | 500uL | EUR 654 |
|
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), CF555 conjugate, Concentration: 0.1mg/mL |
|||
CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody |
|||
| BNUB2884-100 | Biotium | 100uL | EUR 316.8 |
|
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), Concentration: 0.2mg/mL |
|||
CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody |
|||
| BNUB2884-50 | Biotium | 50uL | EUR 486 |
|
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), 1mg/mL |
|||
CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody |
|||
| BNUB2884-500 | Biotium | 500uL | EUR 615.6 |
|
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), Concentration: 0.2mg/mL |
|||
CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody |
|||
| BNCB2884-100 | Biotium | 100uL | EUR 279.6 |
|
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), Biotin conjugate, Concentration: 0.1mg/mL |
|||
CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody |
|||
| BNCB2884-500 | Biotium | 500uL | EUR 654 |
|
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), Biotin conjugate, Concentration: 0.1mg/mL |
|||
CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody |
|||
| BNCH2884-100 | Biotium | 100uL | EUR 279.6 |
|
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody |
|||
| BNCH2884-500 | Biotium | 500uL | EUR 654 |
|
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody |
|||
| BNC942884-100 | Biotium | 100uL | EUR 279.6 |
|
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), CF594 conjugate, Concentration: 0.1mg/mL |
|||
CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody |
|||
| BNC942884-500 | Biotium | 500uL | EUR 654 |
|
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), CF594 conjugate, Concentration: 0.1mg/mL |
|||
CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody |
|||
| BNCAP2884-100 | Biotium | 100uL | EUR 279.6 |
|
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody |
|||
| BNCAP2884-500 | Biotium | 500uL | EUR 654 |
|
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody |
|||
| BNCA2884-250 | Biotium | 250uL | EUR 472.8 |
|
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), APC conjugate, Concentration: 0.1mg/mL |
|||
CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody |
|||
| BNC882884-100 | Biotium | 100uL | EUR 279.6 |
|
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), CF488A conjugate, Concentration: 0.1mg/mL |
|||
CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody |
|||
| BNC882884-500 | Biotium | 500uL | EUR 654 |
|
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), CF488A conjugate, Concentration: 0.1mg/mL |
|||
CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody |
|||
| BNC042884-100 | Biotium | 100uL | EUR 279.6 |
|
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), CF405S conjugate, Concentration: 0.1mg/mL |
|||
CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody |
|||
| BNC042884-500 | Biotium | 500uL | EUR 654 |
|
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), CF405S conjugate, Concentration: 0.1mg/mL |
|||
CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody |
|||
| BNC682884-100 | Biotium | 100uL | EUR 279.6 |
|
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), CF568 conjugate, Concentration: 0.1mg/mL |
|||
CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody |
|||
| BNC682884-500 | Biotium | 500uL | EUR 654 |
|
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), CF568 conjugate, Concentration: 0.1mg/mL |
|||
CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody |
|||
| BNC702884-100 | Biotium | 100uL | EUR 279.6 |
|
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), CF770 conjugate, Concentration: 0.1mg/mL |
|||
CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody |
|||
| BNC702884-500 | Biotium | 500uL | EUR 654 |
|
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), CF770 conjugate, Concentration: 0.1mg/mL |
|||
CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody |
|||
| BNC812884-100 | Biotium | 100uL | EUR 279.6 |
|
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), CF680R conjugate, Concentration: 0.1mg/mL |
|||
CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody |
|||
| BNC812884-500 | Biotium | 500uL | EUR 654 |
|
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), CF680R conjugate, Concentration: 0.1mg/mL |
|||
CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody |
|||
| BNCP2884-250 | Biotium | 250uL | EUR 472.8 |
|
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), PerCP conjugate, Concentration: 0.1mg/mL |
|||
CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody |
|||
| BNCR2884-250 | Biotium | 250uL | EUR 472.8 |
|
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), RPE conjugate, Concentration: 0.1mg/mL |
|||
CD3, T-Cell; Polyclonal |
|||
| A20030 | ScyTek Laboratories | 2 ml | EUR 156 |
CD3, T-Cell; Polyclonal |
|||
| A00030 | ScyTek Laboratories | 6 ml | EUR 255.6 |
CD3, T-Cell; Polyclonal |
|||
| A00030-0100 | ScyTek Laboratories | 100 ml | EUR 2700 |
CD3, T-Cell; Polyclonal |
|||
| A00030.0025 | ScyTek Laboratories | 25 ml | EUR 745.2 |
Jurkat Nuclear Extract (Acute T cell leukemia cells) |
|||
| NJKT-100 | Alpha Diagnostics | 100 ug | EUR 196.8 |
Jurkat Nuclear Extract (Acute T cell leukemia cells) |
|||
| NJKT-50 | Alpha Diagnostics | 50 ug | EUR 153.6 |
anti-Transferrin receptor on activated T-B- cells |
|||
| 518-A-01mg | Virogen | 0,1 mg | EUR 321 |
|
Description: anti-Transferrin receptor on activated T-B-, cells |
|||
anti-Transferrin receptor on activated T-B- cells |
|||
| 518-A-1000ug | Virogen | 1000 ug | EUR 1539 |
|
Description: anti-Transferrin receptor on activated T-B-, cells |
|||
Immortalized Mouse CD4+ CD8+ T Cells (MOHITO) |
|||
| T0131 | ABM | 1x106 cells / 1.0 ml | Ask for price |
Jurkat Whole Cell Lysate (Acute T cell leukemia cells) |
|||
| JKT-100 | Alpha Diagnostics | 100 ug | EUR 196.8 |
Jurkat Whole Cell Lysate (Acute T cell leukemia cells) |
|||
| JKT-50 | Alpha Diagnostics | 50 ug | EUR 153.6 |
Human Cord Blood CD34+ Cells Derived Endothelial Cells |
|||
| HEC23 | Neuromics | 500,000+ Cells | EUR 1296 |
anti-CD3 T-cell |
|||
| 501-A-01mg | Virogen | 0,1 mg | EUR 321 |
|
Description: anti-CD3 T-cell |
|||
anti-CD3 T-cell |
|||
| 501-A-1000ug | Virogen | 1000 ug | EUR 1539 |
|
Description: anti-CD3 T-cell |
|||
LAT Antibody / Linker for Activation of T cells (pY191) |
|||
| RQ4743 | NSJ Bioreagents | 100ul | EUR 356.15 |
|
Description: Linker for activation of T-cells family member 1 (LAT) is required for TCR (T-cell antigen receptor)- and pre-TCR-mediated signaling, both in mature T-cells and during their development. [UniProt] |
|||
Human T- cell- interacting, activating receptor on myeloid cells |
|||
| ELI-41653h | Lifescience Market | 96 Tests | EUR 988.8 |
Mouse T- cell- interacting, activating receptor on myeloid cells |
|||
| ELI-51965m | Lifescience Market | 96 Tests | EUR 1038 |
Nuclear Factor Of Activated T Cells 4 (NFATC4) Antibody |
|||
| 20-abx213560 | Abbexa |
|
|
Nuclear Factor Of Activated T Cells 4 (NFATC4) Antibody |
|||
| 20-abx212093 | Abbexa |
|
|
Nuclear Factor Of Activated T Cells 4 (NFATC4) Antibody |
|||
| 20-abx325638 | Abbexa |
|
|
Nuclear Factor Of Activated T Cells 4 (NFATC4) Antibody |
|||
| 20-abx326051 | Abbexa |
|
|
Nuclear Factor of Activated T Cells 4 (NFATC4) Antibody |
|||
| abx430731-200ul | Abbexa | 200 ul | EUR 343.2 |
Nuclear Factor of Activated T Cells 4 (NFATC4) Antibody |
|||
| abx027250-400ul | Abbexa | 400 ul | EUR 627.6 |
Nuclear Factor of Activated T Cells 4 (NFATC4) Antibody |
|||
| abx027250-80l | Abbexa | 80 µl | EUR 343.2 |
Nuclear Factor of Activated T Cells 4 (NFATC4) Antibody |
|||
| abx433033-200ul | Abbexa | 200 ul | EUR 460.8 |
Rat Anti Rat Rt6.1 (Peripheral T Cells) Monoclonal Antibody |
|||
| CABT-49825RR | Creative Diagnostics | 2 ml | EUR 639.6 |
Dendritic Cells/B Cells Antibody |
|||
| abx412775-02mg | Abbexa | 0.2 mg | EUR 678 |
Immortalized Human Mucosal Associated Invariant T Cells (EM-C5) |
|||
| T0706 | ABM | 1x106 cells / 1.0 ml | Ask for price |
Immortalized Human Mucosal Associated Invariant T Cells (JK-A8) |
|||
| T0708 | ABM | 1x106 cells / 1.0 ml | Ask for price |
Immortalized Human Mucosal Associated Invariant T Cells (MG-A4) |
|||
| T0709 | ABM | 1x106 cells / 1.0 ml | Ask for price |
Immortalized Human Mucosal Associated Invariant T Cells (EM-B11) |
|||
| T0705 | ABM | 1x106 cells / 1.0 ml | Ask for price |
Immortalized Human Mucosal Associated Invariant T Cells (IK-B12) |
|||
| T0707 | ABM | 1x106 cells / 1.0 ml | Ask for price |
Porcine Nuclear factor of activated T- cells, cytoplasmic 1, NFA |
|||
| ELI-05006p | Lifescience Market | 96 Tests | EUR 1113.6 |
anti-CD45 RA B-cells, T-cells, NK-cells |
|||
| 516-A-01mg | Virogen | 0,1 mg | EUR 321 |
|
Description: anti-CD45 RA B-cells, T-cells, NK-cells |
|||
anti-CD45 RA B-cells, T-cells, NK-cells |
|||
| 516-A-1000ug | Virogen | 1000 ug | EUR 1539 |
|
Description: anti-CD45 RA B-cells, T-cells, NK-cells |
|||
5637 cells |
|||
| C0002001 | Addexbio | One Frozen vial | EUR 582 |
FO cells |
|||
| C0003017 | Addexbio | One Frozen vial | EUR 582 |
K1 cells |
|||
| C0025003 | Addexbio | One Frozen vial | EUR 792 |
RD cells |
|||
| C0035001 | Addexbio | One Frozen vial | EUR 546 |
A9 cells |
|||
| P0011007 | Addexbio | One Frozen vial | EUR 651.6 |
BJ cells |
|||
| P0020005 | Addexbio | One Frozen vial | EUR 546 |
ST cells |
|||
| P0028002 | Addexbio | One Frozen vial | EUR 651.6 |
RS4;11 cells |
|||
| C0003012 | Addexbio | One Frozen vial | EUR 546 |
REH cells |
|||
| C0003031 | Addexbio | One Frozen vial | EUR 582 |
4T1 cells |
|||
| C0006004 | Addexbio | One Frozen vial | EUR 546 |
T84 cells |
|||
| C0009008 | Addexbio | One Frozen vial | EUR 546 |
RKO cells |
|||
| C0009012 | Addexbio | One Frozen vial | EUR 546 |
Tumor-derived extracellular vesicles: insight observer effect of exosomes after irradiation.
This review article aims to overcome the kinetic of TDES on cancer cells pre and post-radiotherapy. Radiotherapy is traditionally used for the treatment of some types of cancer; However, there is growing evidence indicates that radiotherapy NTEs exerts on cells close to irradiated cells. In the tumor mass, the cells were irradiated may affect the cells in the non-irradiated in a different way.
Of note, exosomes are nano-scale particles release cells from tumor cells and play a key role in the survival, metastasis and tumor cell immunosuppression. Recent evidence suggests that irradiation has the potential to affect the dynamics of the different signaling pathways such as the exosome biogenesis. Indeed, exosomes act as a mediator between the various cell communication through the transmission of bio-molecules. Because of their important role in cancer biology, exosomes are in the limelight. TDES contains proprietary molecular signatures that they can function as a tumor biomarker in cancer diagnosis is different.
anti-Transferrin receptor on activated T-B- cells |
|||
| 518-A-1000ug | Virogen | 1000 ug | EUR 1539 |
|
Description: anti-Transferrin receptor on activated T-B-, cells |
|||
5637 cells |
|||
| C0002001 | Addexbio | One Frozen vial | EUR 582 |
FO cells |
|||
| C0003017 | Addexbio | One Frozen vial | EUR 582 |
K1 cells |
|||
| C0025003 | Addexbio | One Frozen vial | EUR 792 |
RD cells |
|||
| C0035001 | Addexbio | One Frozen vial | EUR 546 |
A9 cells |
|||
| P0011007 | Addexbio | One Frozen vial | EUR 651.6 |
BJ cells |
|||
| P0020005 | Addexbio | One Frozen vial | EUR 546 |
ST cells |
|||
| P0028002 | Addexbio | One Frozen vial | EUR 651.6 |
RS4;11 cells |
|||
| C0003012 | Addexbio | One Frozen vial | EUR 546 |
REH cells |
|||
| C0003031 | Addexbio | One Frozen vial | EUR 582 |
4T1 cells |
|||
| C0006004 | Addexbio | One Frozen vial | EUR 546 |
T84 cells |
|||
| C0009008 | Addexbio | One Frozen vial | EUR 546 |
RKO cells |
|||
| C0009012 | Addexbio | One Frozen vial | EUR 546 |
H23 cells |
|||
| C0016005 | Addexbio | One Frozen vial | EUR 546 |
H69 cells |
|||
| C0016065 | Addexbio | One Frozen vial | EUR 546 |
H82 cells |
|||
| C0016066 | Addexbio | One Frozen vial | EUR 546 |
A10.7 cells |
|||
| C0018006 | Addexbio | One Frozen vial | EUR 792 |
C32 cells |
|||
| C0020002 | Addexbio | One Frozen vial | EUR 546 |
N87 cells |
|||
| C0023002 | Addexbio | One Frozen vial | EUR 546 |
AGS cells |
|||
| C0023004 | Addexbio | One Frozen vial | EUR 546 |
R2C cells |
|||
| C0028001 | Addexbio | One Frozen vial | EUR 651.6 |
Y79 cells |
|||
| C0029001 | Addexbio | One Frozen vial | EUR 546 |
NB3 cells |
|||
| C0033003 | Addexbio | One Frozen vial | EUR 792 |
STO cells |
|||
| P0011006 | Addexbio | One Frozen vial | EUR 546 |
TM3 cells |
|||
| T0028002 | Addexbio | One Frozen vial | EUR 546 |
MB49 cells |
|||
| C0002004 | Addexbio | One Frozen vial | EUR 932.4 |
K562 cells |
|||
| C0003004 | Addexbio | One Frozen vial | EUR 546 |
U937 cells |
|||
| C0003005 | Addexbio | One Frozen vial | EUR 546 |
Raji cells |
|||
| C0003009 | Addexbio | One Frozen vial | EUR 546 |
BJAB cells |
|||
| C0003016 | Addexbio | One Frozen vial | EUR 651.6 |
Mino cells |
|||
| C0003033 | Addexbio | One Frozen vial | EUR 582 |
B103 cells |
|||
| C0005003 | Addexbio | One Frozen vial | EUR 932.4 |
T47D cells |
|||
| C0006001 | Addexbio | One Frozen vial | EUR 546 |
HeLa cells |
|||
| C0008001 | Addexbio | One Frozen vial | EUR 546 |
SiHa cells |
|||
| C0008002 | Addexbio | One Frozen vial | EUR 546 |
C33A cells |
|||
| C0008003 | Addexbio | One Frozen vial | EUR 546 |
LoVo cells |
|||
| C0009011 | Addexbio | One Frozen vial | EUR 546 |
SW48 cells |
|||
| C0009014 | Addexbio | One Frozen vial | EUR 546 |
H716 cells |
|||
| C0009022 | Addexbio | One Frozen vial | EUR 651.6 |
OE33 cells |
|||
| C0013003 | Addexbio | One Frozen vial | EUR 792 |
A549 cells |
|||
| C0016002 | Addexbio | One Frozen vial | EUR 546 |
H460 cells |
|||
| C0016003 | Addexbio | One Frozen vial | EUR 546 |
A427 cells |
|||
| C0016004 | Addexbio | One Frozen vial | EUR 546 |
H520 cells |
|||
| C0016010 | Addexbio | One Frozen vial | EUR 546 |
H226 cells |
|||
| C0016011 | Addexbio | One Frozen vial | EUR 546 |
H358 cells |
|||
| C0016016 | Addexbio | One Frozen vial | EUR 546 |
H441 cells |
|||
| C0016019 | Addexbio | One Frozen vial | EUR 546 |
H596 cells |
|||
| C0016020 | Addexbio | One Frozen vial | EUR 546 |
H526 cells |
|||
| C0016052 | Addexbio | One Frozen vial | EUR 546 |
H446 cells |
|||
| C0016054 | Addexbio | One Frozen vial | EUR 651.6 |
H187 cells |
|||
| C0016061 | Addexbio | One Frozen vial | EUR 546 |
H209 cells |
|||
| C0016063 | Addexbio | One Frozen vial | EUR 546 |
H847 cells |
|||
| C0016067 | Addexbio | One Frozen vial | EUR 651.6 |
H660 cells |
|||
| C0016068 | Addexbio | One Frozen vial | EUR 834 |
A673 cells |
|||
| C0016074 | Addexbio | One Frozen vial | EUR 546 |
H524 cells |
|||
| C0016077 | Addexbio | One Frozen vial | EUR 651.6 |
H211 cells |
|||
| C0016078 | Addexbio | One Frozen vial | EUR 651.6 |
H146 cells |
|||
| C0016080 | Addexbio | One Frozen vial | EUR 546 |
H889 cells |
|||
| C0016081 | Addexbio | One Frozen vial | EUR 651.6 |
H128 cells |
|||
| C0016083 | Addexbio | One Frozen vial | EUR 651.6 |
Vcap cells |
|||
| C0019001 | Addexbio | One Frozen vial | EUR 546 |
8505C cells |
|||
| C0025002 | Addexbio | One Frozen vial | EUR 792 |
BeWo cells |
|||
| C0030001 | Addexbio | One Frozen vial | EUR 546 |
HASM cells |
|||
| P0001001 | Addexbio | One Frozen vial | EUR 932.4 |
HBSM cells |
|||
| P0007001 | Addexbio | One Frozen vial | EUR 932.4 |
SCBN cells |
|||
| P0010001 | Addexbio | One Frozen vial | EUR 651.6 |
L929 cells |
|||
| P0011012 | Addexbio | One Frozen vial | EUR 546 |
VERO cells |
|||
| P0014002 | Addexbio | One Frozen vial | EUR 546 |
MDCK cells |
|||
| P0014003 | Addexbio | One Frozen vial | EUR 546 |
C127 cells |
|||
| S0006001 | Addexbio | One Frozen vial | EUR 582 |
Hs27 cells |
|||
| T0020010 | Addexbio | One Frozen vial | EUR 546 |
Daudi cells |
|||
| C0003010 | Addexbio | One Frozen vial | EUR 546 |
MC116 cells |
|||
| C0003021 | Addexbio | One Frozen vial | EUR 582 |
U87MG cells |
|||
| C0005002 | Addexbio | One Frozen vial | EUR 546 |
CaSKi cells |
|||
| C0008004 | Addexbio | One Frozen vial | EUR 546 |
SW480 cells |
|||
| C0009001 | Addexbio | One Frozen vial | EUR 546 |
SW620 cells |
|||
| C0009002 | Addexbio | One Frozen vial | EUR 546 |
HCT15 cells |
|||
| C0009010 | Addexbio | One Frozen vial | EUR 546 |
Hep3B cells |
|||
| C0015001 | Addexbio | One Frozen vial | EUR 546 |
HepG2 cells |
|||
| C0015002 | Addexbio | One Frozen vial | EUR 546 |
Calu3 cells |
|||
| C0016001 | Addexbio | One Frozen vial | EUR 546 |
H1703 cells |
|||
| C0016008 | Addexbio | One Frozen vial | EUR 651.6 |
H1975 cells |
|||
| C0016013 | Addexbio | One Frozen vial | EUR 651.6 |
H1650 cells |
|||
| C0016015 | Addexbio | One Frozen vial | EUR 651.6 |
H2228 cells |
|||
| C0016017 | Addexbio | One Frozen vial | EUR 651.6 |
H2170 cells |
|||
| C0016018 | Addexbio | One Frozen vial | EUR 546 |
H1581 cells |
|||
| C0016028 | Addexbio | One Frozen vial | EUR 651.6 |
H2444 cells |
|||
| C0016038 | Addexbio | One Frozen vial | EUR 651.6 |
H69AR cells |
|||
| C0016046 | Addexbio | One Frozen vial | EUR 651.6 |
Interestingly, radiotherapy and IR can also contribute to change the dynamics of exosome secretion. Most likely, the contents of exosomes in irradiated cells was different than the exosomes derived from non-irradiated BCs. irradiated cells release exosomes with exclusive content NTEs mediate in BC. Given the variation in cell type, dose IR, and radio-resistance or radio-sensitivity of different cancers, there is, however, a contradiction in exosomes irradiation features and activities on neighboring cells.